Skip to main content
Top
Published in: Drugs & Aging 12/2007

01-12-2007 | Original Research Article

Associations between Use of Benzodiazepines or Related Drugs and Health, Physical Abilities and Cognitive Function

A Non-Randomised Clinical Study in the Elderly

Authors: Juha Puustinen, Janne Nurminen, Matti Kukola, Tero Vahlberg, Kari Laine, Sirkka-Liisa Kivelä

Published in: Drugs & Aging | Issue 12/2007

Login to get access

Abstract

Objective: To describe associations between the use of benzodiazepines or related drugs (BZDs/RDs) and health, functional abilities and cognitive function in the elderly.
Methods: A non-randomised clinical study of patients aged ≥65 years admitted to acute hospital wards during 1 month. 164 patients (mean age ± standard deviation [SD] 81.6 ± 6.8 years) were admitted. Of these, nearly half (n = 78) had used BZDs/RDs before admission, and the remainder (n = 86) were non-users. Cognitive ability was assessed by the Mini-Mental State Examination (MMSE). Patients scoring ≥20 MMSE sum points were interviewed (n = 79) and questioned regarding symptoms and functional abilities during the week prior to admission. Data on use of BZDs/RDs before admission, current medications and discharge diagnoses were collected from medical records. Health, physical abilities and cognitive function were compared between BZD/RD users and non-users, and adjustments were made for confounding variables. The residual serum concentrations of oxazepam, temazepam and zopiclone were analysed.
Results: The mean ± SD duration of BZD/RD use was 7 ± 7 years (range 1–31). Two or three BZDs/RDs were concomitantly taken by 26% of users (n = 20). Long-term use of these drugs was associated with female sex and use of a higher number of drugs with effects on the CNS, which tended to be related to diagnosed dementia. After adjustment for these variables as confounders, use of BZDs/RDs was not associated with cognitive function as measured by the MMSE. However, use of BZDs/RDs was associated with dizziness, inability to sleep after awaking at night and tiredness in the mornings during the week prior to admission and with stronger depressive symptoms measured at the beginning of the hospital stay. Use of BZDs/RDs tended to be associated with a reduced ability to walk and shorter night-time sleep during the week prior to admission. A higher residual serum concentration of temazepam correlated with a lower MMSE sum score after adjustment for confounding variables.
Conclusions: Long-term use and concomitant use of more than one BZD/RD were common in elderly patients hospitalised because of acute illnesses. Long-term use was associated with daytime and night-time symptoms indicative of poorer health and potentially caused by the adverse effects of these drugs.
Literature
1.
go back to reference Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11(2): 97–104PubMedCrossRef Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11(2): 97–104PubMedCrossRef
2.
go back to reference Barker MJ, Greenwood KM, Jackson M, et al. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18(1): 37–48PubMedCrossRef Barker MJ, Greenwood KM, Jackson M, et al. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18(1): 37–48PubMedCrossRef
3.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17(9): 874–83PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17(9): 874–83PubMedCrossRef
4.
go back to reference Paakkari P, Voipio T. The growing consumption of hypnotics and sedatives evens out. TABU (drug information from the National Agency for Medicines, Finland) 2005; (3): 37–8 Paakkari P, Voipio T. The growing consumption of hypnotics and sedatives evens out. TABU (drug information from the National Agency for Medicines, Finland) 2005; (3): 37–8
5.
go back to reference Ohayon MM, Caulet M, Priest RG, et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51(3): 273–83PubMedCrossRef Ohayon MM, Caulet M, Priest RG, et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51(3): 273–83PubMedCrossRef
6.
go back to reference Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63(9): 817–25PubMedCrossRef Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63(9): 817–25PubMedCrossRef
7.
go back to reference Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18(5): 297–328PubMedCrossRef Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18(5): 297–328PubMedCrossRef
8.
go back to reference Barker MJ, Greenwood KM, Jackson M, et al. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004; 19(3): 437–54PubMedCrossRef Barker MJ, Greenwood KM, Jackson M, et al. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004; 19(3): 437–54PubMedCrossRef
9.
go back to reference Poyares D, Guilleminault C, Ohayon MM, et al. Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res 2004; 38(3): 327–34PubMedCrossRef Poyares D, Guilleminault C, Ohayon MM, et al. Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res 2004; 38(3): 327–34PubMedCrossRef
10.
go back to reference Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331(7526): 1169–76PubMedCrossRef Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331(7526): 1169–76PubMedCrossRef
12.
go back to reference National Agency of Medicines. Classification of medicines (ATC) and defined daily doses (DDD) 2004. Helsinki: National Agency of Medicines, 2004 National Agency of Medicines. Classification of medicines (ATC) and defined daily doses (DDD) 2004. Helsinki: National Agency of Medicines, 2004
13.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–98PubMedCrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–98PubMedCrossRef
14.
go back to reference Salokangas RK, Stengard E, Poutanen O. DEPS: a new tool in screening for depression. Duodecim 1994; 110(12): 1141–8PubMed Salokangas RK, Stengard E, Poutanen O. DEPS: a new tool in screening for depression. Duodecim 1994; 110(12): 1141–8PubMed
15.
go back to reference World Health Organization. Tautiluokitus ICD-10 (Classification of Diseases ICD-10). Rauma: Kirjapaino Oy West Point, 1995 World Health Organization. Tautiluokitus ICD-10 (Classification of Diseases ICD-10). Rauma: Kirjapaino Oy West Point, 1995
16.
go back to reference Laakkonen UM, Heiskanen A. Screening and quantitation of benzodiazepines in serum samples. In: Kaempe B, editor. T.I.A.F.T., proceedings of the 29th international meeting. Copenhagen: Mackeenzie, 1991: 262–6 Laakkonen UM, Heiskanen A. Screening and quantitation of benzodiazepines in serum samples. In: Kaempe B, editor. T.I.A.F.T., proceedings of the 29th international meeting. Copenhagen: Mackeenzie, 1991: 262–6
17.
go back to reference Byles JE, Mishra GD, Harris MA, et al. The problems of sleep for older women: changes in health outcomes. Age Ageing 2003; 32(2): 154–63PubMedCrossRef Byles JE, Mishra GD, Harris MA, et al. The problems of sleep for older women: changes in health outcomes. Age Ageing 2003; 32(2): 154–63PubMedCrossRef
18.
go back to reference Christer GM, Hublin CGM, Partinen MM. The extent and impact of insomnia as a public health problem. Prim Care Companion J Clin Psychiatry 2002; 4Suppl. 1: 8–12 Christer GM, Hublin CGM, Partinen MM. The extent and impact of insomnia as a public health problem. Prim Care Companion J Clin Psychiatry 2002; 4Suppl. 1: 8–12
19.
go back to reference Nielsen GH, Nordhus JH, Kvale G. Clinical geropsychology. In: Nordhus JH, Vandenbos GR, Berg S, et al., editors. Insomnia in older adults. Washington, DC: American Psychiatric Association, 1998: 167–75 Nielsen GH, Nordhus JH, Kvale G. Clinical geropsychology. In: Nordhus JH, Vandenbos GR, Berg S, et al., editors. Insomnia in older adults. Washington, DC: American Psychiatric Association, 1998: 167–75
20.
go back to reference Morgan K. Sleep problems in the elderly. In: Woods RT, editor. Handbook of the clinical psychology of ageing. Chichester: John Wiley & Sons, 1996: 303–14 Morgan K. Sleep problems in the elderly. In: Woods RT, editor. Handbook of the clinical psychology of ageing. Chichester: John Wiley & Sons, 1996: 303–14
21.
go back to reference Neubauer DN. Sleep problems in the elderly. Am Fam Physician 1999; 59(9): 2551–8, 2559–60PubMed Neubauer DN. Sleep problems in the elderly. Am Fam Physician 1999; 59(9): 2551–8, 2559–60PubMed
22.
go back to reference Socialstyrelsen/National Board of Social Welfare, Sweden. Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapia [indicators for evaluating the quality of medication therapy in the aged]. Stockholm: Socialstyrelsen/National Board of Social Welfare, Sweden, 2003: report no. 2003-110-20 Socialstyrelsen/National Board of Social Welfare, Sweden. Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapia [indicators for evaluating the quality of medication therapy in the aged]. Stockholm: Socialstyrelsen/National Board of Social Welfare, Sweden, 2003: report no. 2003-110-20
Metadata
Title
Associations between Use of Benzodiazepines or Related Drugs and Health, Physical Abilities and Cognitive Function
A Non-Randomised Clinical Study in the Elderly
Authors
Juha Puustinen
Janne Nurminen
Matti Kukola
Tero Vahlberg
Kari Laine
Sirkka-Liisa Kivelä
Publication date
01-12-2007
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2007
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200724120-00007

Other articles of this Issue 12/2007

Drugs & Aging 12/2007 Go to the issue

Acknowledgments

Acknowledgement

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.